Technology and Life Sciences
New tech and life sciences companies can grow quickly and reach very high valuations. We work with them from launch to exit, to increase the chances of success and enable everyone involved to fully reap the benefits.


With great vision, sound judgement, the right financing, hard work and, on occasion, some good fortune, a tech start-up can define a new business segment or develop a new foundational technology; and a life sciences business can develop a cutting-edge therapy or a new category of medical device.

We’ve been involved in advising tech and life sciences companies for decades – including pioneers in software development, AI, data science, SAAS offerings, video games or other digital media, semi-conductor or optoelectronics/laser design, drug discovery, biotech research, medical device development, pharmaceutical marketing, and much else besides. They range from the earliest start-ups (including many that have raised significant VC rounds before successful liquidity events, and Scotland’s first unicorn), to large international corporates (helping many of them with acquisitions of UK tech/life sciences businesses).

We are also an active part of the entrepreneurial ecosystem through a number of pro bono mentoring arrangements and our work with various incubators and accelerators.

Scotland’s deep research base generates a diverse range of technology and life sciences innovations, and our clients have been active across the breadth of that research and development – including in drug discovery, medical device development, specialty pharmaceuticals, semiconductor design, battery tech development, optoelectronics and laser devices, codec technologies, AI, data science, network and cyber security and video games and other digital media. We bring to bear our experience in all these sectors to help our clients accomplish their goals.

Our lawyers understand the commercial drivers of technology and life sciences businesses and have the experience to foresee potential issues before they arise – because we succeed when our clients do, and we have a decades-long track record of helping our clients to do so.

Our expertise includes:

  • Start-ups, scale-ups and venture capital
  • Private equity
  • Mergers and acquisitions
  • Collaborations and joint ventures
  • Corporate tax
  • Equity incentives
  • Employment and immigration
  • Data protection and privacy
  • Intellectual property and brand protection
  • R&D arrangements, clinical trial agreements and technology transfers
  • Competition and regulatory advice
  • Commercial contracts
  • All other “go to market” matters

We have expertise in all areas of technology and life sciences, including:


Sophie Bailey

Senior Associate

Joanna Boag-Thomson

Partner

Leonore Dupont

Director

Joseph Fitzgibbon

Senior Associate

Nikki Forde

Solicitor

Roddy Forgie

Director

Madeleine Gill

Solicitor

Olivia Greener

Senior Solicitor

Joanne Griffin

Consultant Solicitor

Morag Hutchison

Partner

Cameron Kane

Associate

Ruairidh Leishman

Senior Associate

Cath Macrae

Senior Associate

Gillian Moore

Director

John Morrison

Partner

Ben Pilbrow

Partner

Alison Rochester

Partner

Euan Small

Senior Solicitor

Donald Smith

Partner

Tom Swan

Partner

Stephen Trombala

Partner

John Vassiliou

Director and Head of Immigration

Close


Related articles and insights: Technology and Life Sciences

23 December 2025

Getty Images v Stability AI: A long-awaited judgement that leaves AI stakeholders waiting longer

Contributor: Ruairidh Leishman

Insight into the widely anticipated AI copyright infringement case, Getty Images v. Stability AI.

15 December 2025

The use of drones in the countryside

Contributor: Ruairidh Leishman

Landowners have long had to deal with individuals who wish to access their land. Now they also have to consider people who want to enter the airspace above it.

10 December 2025

EMI options – How to get them right

Contributor: Gavin Charlton

Following the expansion of qualifying companies for EMI options in the Autumn Budget we look at the most common mistakes made when implementing an EMI plan and how businesses can avoid them.

9 December 2025

AI in Real Estate – Nirvana or new bubble?

Contributor: Scott Ritchie

How is AI affecting real estate? Developers, operators, funders, and industry bodies in the UK heard from American real estate expert Brad Hargreaves on what he is seeing in the US market.

3 December 2025

The benefits of EMI share option plans and why more companies should take advantage of them

Contributor: Gavin Charlton

The Autumn Budget expanded the scope of companies who will qualify for Enterprise Management Incentive Plans. To help those considering this type of employee share option plan, we look at the main motivations behind EMI plans and how they can benefit businesses and employees.

26 November 2025

Some budget good news – EMI employee share option plans improved

Contributor: Gavin Charlton

A look into the changes to Enterprise Management Incentives (EMI) employee share option plans is in the Autumn 2025 Budget.

Contact us